ArticleBMC cancer2024

Impact of chronic obstructive pulmonary disease on the efficacy and safety of neoadjuvant immune checkpoint inhibitors combined with chemotherapy for resectable non-small cell lung cancer: a retrospective cohort study.

Weigang Dong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.